Schrodinger, Inc. Common Stock SDGR
Analyst Ratings
- Consensus
- Moderate Buy — 3 Buy · 3 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $20.50 (-32.2% downside)
Key Stats
- Today's Range
- $24.09 – $30.41
- 50-Day Range
- $14.61 – $30.41
- 52-Week Range
- $10.95 – $30.41
- Volume
- 9.03 million shs
- Average Volume
- 1.51 million shs
- Market Cap
- $1.79 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.44
- Price / Sales
- 6.91
Short Interest
- Short Interest
- 0.11%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $259.04 million
- Net Income
- $-54,335,000
- Net Margin
- -20.98%
- Return on Equity
- -16.52%
- Debt-to-Equity
- —
About Schrodinger, Inc. Common Stock
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Related Stocks
Compare head-to-head: SDGR vs LLY·SDGR vs JNJ·SDGR vs ABBV·SDGR vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.